Shibin Qu

4.0k citations
22 papers · 2.9k indexed · 1 hit paper · h-index 18
Topics
MicroRNA in disease regulation (11 papers)Circular RNAs in diseases (9 papers)Cancer-related molecular mechanisms research (9 papers)

In The Last Decade

Shibin Qu

22 papers receiving 2.9k citations

Hit Papers

Circular RNA: A new star of noncoding RNAs201520262018202220154008001.2k

Peers

Shibin Qu
Comparison fields: 5 of 100
  • Molecular Biology 2.5k
  • Cancer Research 2.3k
  • Immunology 153
  • Oncology 132
  • Biomedical Engineering 118
Replace Xisheng Yang with:
Xisheng Yang China
Linhui Liang China
Chunyang Bao China
Nunu Huang China
Lotte Victoria Winther Stagsted Denmark
Mihnea P. Dragomir Germany
Sidney W. Fu United States
Masami Ueda Japan
Marika Salmanidis Australia
Dorothee Wernicke United States
Shibin Qu relative to Xisheng Yang China Xisheng Yang's profile →
Citations per field
00.5×5.9×
Xisheng Yang · 1×
Citations per year

Countries citing papers authored by Shibin Qu

Since Specialization
Citations

This map shows the geographic impact of Shibin Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shibin Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shibin Qu more than expected).

Fields of papers citing papers by Shibin Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shibin Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shibin Qu. The network helps show where Shibin Qu may publish in the future.

Co-authorship network of co-authors of Shibin Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Shibin Qu. A scholar is included among the top collaborators of Shibin Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shibin Qu. Shibin Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 19
2 4
3 14
4 8
5 1
6 48
7 73
8 30
9 219
10 37
11 122
12 103
13 42
14 337
15 22
16
Circular RNA: A new star of noncoding RNAsbreakdown →
1419
17 51
18 85
19 34
20 17

About Shibin Qu

Shibin Qu is a scholar working on Cancer Research, Molecular Biology and Pharmacy, having authored 22 papers that have together received 2.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (9 papers) and Cancer-related molecular mechanisms research (9 papers). The work is most often cited by research in Cancer Research (2.3k citations), Molecular Biology (2.5k citations) and Immunology (153 citations). Shibin Qu has collaborated with scholars based in China, United States and Denmark. Frequent co-authors include Haimin Li, Runze Shang, Xisheng Yang, Jianlin Wang, Kefeng Dou, Xiaolei Li, Yuan Gao, Wei Sun, Wenjie Song and Xuan Zhang. Their work appears in journals such as Gastroenterology, Molecular Cancer and Cancer Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026